AU1188492A - Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis - Google Patents

Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

Info

Publication number
AU1188492A
AU1188492A AU11884/92A AU1188492A AU1188492A AU 1188492 A AU1188492 A AU 1188492A AU 11884/92 A AU11884/92 A AU 11884/92A AU 1188492 A AU1188492 A AU 1188492A AU 1188492 A AU1188492 A AU 1188492A
Authority
AU
Australia
Prior art keywords
prevention
treatment
pharmaceutical combination
postmenopausal osteoporosis
postmenopausal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11884/92A
Inventor
Paolo Chiesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Publication of AU1188492A publication Critical patent/AU1188492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
AU11884/92A 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis Abandoned AU1188492A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI910253A IT1244697B (en) 1991-02-01 1991-02-01 PHARMACEUTICAL ASSOCIATION FOR THE PREVENTION AND TREATMENT OF POST-MENOPAUSAL OSTEOPOROSIS
ITMI91A000253 1991-02-01

Publications (1)

Publication Number Publication Date
AU1188492A true AU1188492A (en) 1992-09-07

Family

ID=11358374

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11884/92A Abandoned AU1188492A (en) 1991-02-01 1992-01-28 Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

Country Status (9)

Country Link
EP (1) EP0569415A1 (en)
AU (1) AU1188492A (en)
CA (1) CA2101547A1 (en)
HU (1) HUT64848A (en)
IE (1) IE920219A1 (en)
IT (1) IT1244697B (en)
NZ (1) NZ241418A (en)
WO (1) WO1992013538A1 (en)
ZA (1) ZA92661B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023716A1 (en) * 1993-04-16 1994-10-27 Tufts University School Of Medicine Method for treatment of menopausal and premenstrual symptoms
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
US6319914B1 (en) 1993-11-05 2001-11-20 Apollo Biopharmaceuticals, Inc. Cytoprotective effect of polycyclic phenolic compounds
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
JP2004524354A (en) * 2001-03-16 2004-08-12 ワイス Estrogen replacement therapy
WO2008051586A2 (en) 2006-10-24 2008-05-02 Krempin David W Anti-resorptive and bone building dietary supplements and methods of use

Also Published As

Publication number Publication date
ITMI910253A0 (en) 1991-02-01
ZA92661B (en) 1992-10-28
IT1244697B (en) 1994-08-08
HUT64848A (en) 1994-03-28
WO1992013538A1 (en) 1992-08-20
ITMI910253A1 (en) 1992-08-01
NZ241418A (en) 1993-03-26
HU9302183D0 (en) 1993-10-28
EP0569415A1 (en) 1993-11-18
CA2101547A1 (en) 1992-08-02
IE920219A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
AU2087992A (en) Pharmaceutical combination formulation
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
AU3406893A (en) Method and composition for the treatment of osteoporosis
IL106521A0 (en) Pharmaceutical composition for the treatment or prevention of elevated intraocular pressure
AU6160594A (en) Diabetes prevention and treatment
AU5853894A (en) Use of vitamin d glycosides for the treatment or prevention of osteoporosis
GB9114950D0 (en) Pharmaceutical formulation
AU1188492A (en) Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis
HU9300804D0 (en) Pharmaceutical preparatives
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
AU1189392A (en) Pharmaceutical agent
AU5270693A (en) Pharmaceutical composition for preventing or treating arteriosclerosis
GB9216061D0 (en) Pharmaceutical combination formulation
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
EP0653208A3 (en) Pharmaceutical agents for treatment or prevention of sunburn.
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
GB9216102D0 (en) Pharmaceutical substances
AU5970294A (en) Agents for the prevention and treatment of lesch-nyhan syndrome
GB9212968D0 (en) Pharmaceutical formulation
GB9221694D0 (en) Pharmaceutical formulation
ZA925931B (en) Medicinal treatment
IL102796A0 (en) Medicinal treatment
IL105105A0 (en) Pharmaceutical dosage form
IL122731A0 (en) Pharmaceutical compositions for the treatment of arrhythmia